Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Fatal liver mass rupture in a common-variable-immunodeficiency patient with probable nodular regenerating hyperplasia

Fig. 1

Hepatic imaging AD. The initial multiphasic CT. A The non-contrasted image shows no abnormal intrahepatic bleeding. B The arterial phase shows multiple poorly-defined, arterial-enhancing nodules scattered throughout both hepatic lobes (white arrows). In portovenous phase C and 5 min-delayed phase D, these nodules remain iso- to hyperattenuating compared to the adjacent liver parenchyma. Hepatic imaging EF. The 7-month follow-up CT. E The non-contrasted image shows multiple areas of intrahepatic bleeding (black arrowheads) and intraperitoneal bleeding (black arrows). F The portovenous phase demonstrates disruption of the liver capsule (white arrowhead), suggesting rupture of these hypervascular liver lesions

Back to article page